D. Gathara's research while affiliated with KEMRI-Wellcome Trust Research Programme and other places
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Publications (8)
Abstract
Background:
Globally, 40% of all tuberculosis (TB) cases, 65% paediatric cases and 75% multi-drug resistant TB(MDR-TB) cases are missed due to underreporting and/or under diagnosis. A recent Kenyan TB prevalence survey found that a significant number of TB cases are being missed here. Understanding spatial distribution and patterns of use...
Background: The introduction of Gene Xpert® MTB/RIF assay (“genexpert”; Cepheid, Sunnyvale, USA) (GeneXpert) in the diagnosis of Tb has been a practice changer not only in the speed of diagnosis but also in the early and prompt identification of rifampicin resistance. Data generated from the use of geneXpert is managed in the GeneXpert Laboratory I...
Background: TB-HIV co-infection remains a glaring challenge particularly in low resource countries. The end TB strategy is focused towards the reduction of all TB related mortality by 95% by 2035
Objective: To analyze the survival patterns of TB-HIV co-infected patients in Kiambu County
Design: Retrospective cross-sectional study Setting: Kiambu...
Citations
... These findings are in line with the WHO newsletter that indicated that the number of people developing TB and dying from the disease could be much higher in 2021 and 2022 mainly because of the COVID-19 pandemic [65] and since this was based on the general population, it is concerning that the same trend is witnessed among children below 15 years. These findings also confirm those by Oliwa et al. [66] who indicated that notification data may underestimate the TB burden among children while Mbithi et al. [67] reported a decrease in TB diagnosis in Kenya by an average of 28% in the year 2020. In addition, the conclusions from Makori et al. [30] about the need to intensify TB case finding among younger, especially pediatric populations affirm the findings of this study. ...
![[object Object]](https://i1.rgstatic.net/ii/profile.image/279483803291655-1443645539343_Q64/Jacquie-Oliwa-2.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/694596489183232-1542616116173_Q64/Josh-Maina.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/310081470566402-1450940591408_Q64/Philip-Ayieko-2.jpg)
![[object Object]](https://i1.rgstatic.net/ii/profile.image/277172674678787-1443094523532_Q64/Mike-English.jpg)
